AHSA1 Antikörper (AA 19-337)
Kurzübersicht für AHSA1 Antikörper (AA 19-337) (ABIN5776005)
Target
Alle AHSA1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 19-337
-
Verwendungszweck
- Human AHSA1 antibody
-
Aufreinigung
- Purified
-
Immunogen
- Recombinant human AHA1(19-337aa) purified from E. coli
-
Isotyp
- IgG2b kappa
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Phosphate-Buffered Saline ( pH 7.4) with 0.02 % Sodium Azide, 10 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing cycles
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
-
-
- AHSA1 (Activator of HSP90 ATPase Activity 1 (AHSA1))
-
Andere Bezeichnung
- AHSA1
-
Hintergrund
- The Co-chaperone AHA1 (Activator of HSP90 ATPase-1) is proposed to function as an ATPase activating protein. May affect a step in the endoplasmic reticulum to Golgi trafficking. It expressed in numerous tissues, including brain, heart, skeletal muscle and kidney and, at lower levels, liver and placenta.
-
NCBI Accession
- NP_036243
Target
-